Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT00048932

Public ClinicalTrials.gov record NCT00048932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn if abatacept is safe when co-administered with other approved rheumatoid arthritis medications.

Study identification

NCT ID
NCT00048932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
1,795 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2002 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Nov 24, 2011

2002 – 2009

United States locations

U.S. sites
44
U.S. states
28
U.S. cities
44
Facility City State ZIP Site status
Local Institution Decatur Alabama — —
Local Institution Paradise Arizona — —
Local Institution Phoenix Arizona — —
Local Institution Tucson Arizona — —
Local Institution San Francisco California — —
Local Institution Loveland Colorado — —
Local Institution Hamden Connecticut — —
Local Institution Lake Worth Florida — —
Local Institution Largo Florida — —
Local Institution Blairsville Georgia — —
Local Institution Chicago Illinois — —
Local Institution Evansville Indiana — —
Local Institution Indianapolis Indiana — —
Local Institution Wichita Kansas — —
Local Institution Louisville Kentucky — —
Local Institution New Orleans Louisiana — —
Local Institution Baltimore Maryland — —
Local Institution Cumberland Maryland — —
Local Institution Westminster Maryland — —
Local Institution Boston Massachusetts — —
Local Institution Grand Rapids Michigan — —
Local Institution Royal Oak Michigan — —
Local Institution Toms River New Jersey — —
Local Institution Los Alamos New Mexico — —
Local Institution New York New York — —
Local Institution Durham North Carolina — —
Local Institution Hickory North Carolina — —
Local Institution Canton Ohio — —
Local Institution Cleveland Ohio — —
Local Institution Columbus Ohio — —
Local Institution Elyria Ohio — —
Local Institution Youngstown Ohio — —
Local Institution Oklahoma City Oklahoma — —
Local Institution Wyomissing Pennsylvania — —
Local Institution Columbia South Carolina — —
Local Institution Sioux Falls South Dakota — —
Local Institution Ducktown Tennessee — —
Local Institution Nashville Tennessee — —
Local Institution Richmond Virginia — —
Local Institution Edmonds Washington — —
Local Institution Olympia Washington — —
Local Institution Tacoma Washington — —
Local Institution Menomonee Falls Wisconsin — —
Local Institution Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00048932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00048932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →